DOYLE THOMAS JAMES (SVP, Finance & Accounting) sold 3.1% of their position (4.61K shares) of KURA ONCOLOGY, INC. on the open market
Open‑market sale worth $48.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/29/2026ACC: 0001193125-26-407936
Officer· SVP, Finance & Accounting
Since Feb 2022
-4.61K
Net shares
Net seller
$48.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.61K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.61K
Price / share
$10.50
Trade value
$48.36K
% of position
3.1%
9/28/2026
147.03K→142.43K
Total
Net shares
−4.61K
Net value
-$48.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/28/2026 | S · Sale | −4.61K | $10.50 | $48.36K | 3.1% | 147.03K | 142.43K |
| Total | −4.61K | -$48.36K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned500.00
Total
500.00 indirect500.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 500.00 | Indirect |
| Total | 500.00 | 500.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported